TipRanks
Go Ultimate55% OFF

Starling Oncology Institute (STLN) Stock Forecast & Price Target

213 Followers
See the Price Targets and Ratings of:

STLN Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Starling Oncology Institute in the past 3 months

STLN Stock 12 Month Forecast

$10.00▲(57.73% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Starling Oncology Institute in the last 3 months. The average price target is $10.00 with a high forecast of $11.00 and a low forecast of $9.00. The average price target represents a 57.73% change from the last price of $6.34.
Highest Price Target$11.00Average Price Target$10.00Lowest Price Target$9.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for STLN
Price TargetFollowArticle
Needham$7→$9buy41.96%UpsideReiterated10/14/26
B. Riley Securities$8→$11buy73.50%UpsideReiterated08/07/26
BTIG$8→$9buy41.96%UpsideReiterated07/15/26
Lake Street$10buy57.73%UpsideInitiated07/06/26
Noble Financial$8buy26.18%UpsideReiterated05/08/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Starling Oncology Institute

3 Months
Success Rate7/8 ratings generated profit
88%
Average Return
+24.59%

Copying David Larsen's trades and holding each position for 3 Months would result in 87.50% of your transactions generating a profit, with an average return of +24.59% per trade.

1 Year
Robert LeBoyer
Robert LeBoyerNoble Financial
Success Rate7/7 ratings generated profit
100%
Average Return
+74.46%

Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +74.46% per trade.

2 Years
Success Rate8/8 ratings generated profit
100%
Average Return
+82.31%

Copying David Larsen's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +82.31% per trade.

STLN Analyst Recommendation Trends

05101520Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for STLN
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy46541
Buy33433
Hold00000
Sell00000
Strong Sell00000
total79974

In the current month, STLN has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. STLN average Analyst price target in the past 3 months is 10.00.

STLN Financial Forecast

$-2$-1.5$-1$-0.5$0Q4 2025Q2 2026Q3 2026
High$-0.04
Consensus$-0.05
Low$-0.07

STLN Earnings Forecast

Next quarter’s earnings estimate for STLN is -$0.05 with a range of -$0.07 to -$0.04. The previous quarter’s EPS was -$0.08. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$136.6M$145.3M$154.1M$162.8M$171.6MQ4 2025Q2 2026Q3 2026
High$172M
Consensus$169M
Low$165M

STLN Sales Forecast

Next quarter’s sales forecast for STLN is $168.68M with a range of $164.90M to $171.60M. The previous quarter’s sales results were $161.28M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

STLN Stock Forecast FAQ

What is STLN’s average 12-month price target, according to analysts?
Based on analyst ratings, Starling Oncology Institute’s 12-month average price target is $10.00.
What is STLN’s upside potential, based on the analysts’ average price target?
Starling Oncology Institute has 57.73% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is STLN a Buy, Sell or Hold?
Starling Oncology Institute has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Starling Oncology Institute’s price target?
The average price target for Starling Oncology Institute is $10.00. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $11.00, the lowest forecast is $9.00. The average price target represents a 57.73% increase from the current price of $6.34.
What do analysts say about Starling Oncology Institute?
Starling Oncology Institute’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of STLN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.